Please login to the form below

Not currently logged in
Email:
Password:

dermatology

This page shows the latest dermatology news and features for those working in and with pharma, biotech and healthcare.

Novartis gains label boost for Cosentyx

Novartis gains label boost for Cosentyx

We are reimagining the well-being of patients living with all facets of psoriatic arthritis," said Eric Hughes, Global Development Unit Head, Immunology, Hepatology and Dermatology.

Latest news

  • Big Pharma, Little Pharma Big Pharma, Little Pharma

    The company took a big risk when it bought Allergan’s dermatology portfolio.

  • New data keeps AbbVie’s star pipeline therapies on track New data keeps AbbVie’s star pipeline therapies on track

    AbbVie has presented new data on its risankizumab candidate in psoriasis and upadacitinib in atopic dermatitis that suggest it has a potentially lucrative dermatology franchise on the way. ... At the European Academy of Dermatology and Venereology (EADV)

  • Novartis sells off part of Sandoz portfolio Novartis sells off part of Sandoz portfolio

    The move, which will see Sandoz do away with its US dermatology and generic oral solid portfolios, allows the firm to re-focus its pipeline, says the unit's chief executive ... In return Aurobindo is set to receive approximately 300 products, as well as

  • Realm toppled by second mid-stage trial flop Realm toppled by second mid-stage trial flop

    The company also thinks that its hypochlorous acid formulations could have potential “in immune-mediated diseases generally, ”although programmes outside of dermatology are at the very early stages of development.

  • FDA gives breakthrough status to Xolair for food allergies FDA gives breakthrough status to Xolair for food allergies

    Since then Roche and Novartis have built on the drug’s approved uses, expanding its label in allergic asthma and adding a dermatology indication – the treatment of chronic idiopathic urticaria (hives) –

More from news
Approximately 12 fully matching, plus 180 partially matching documents found.

Latest Intelligence

  • Leo has its eyes on the prize Leo has its eyes on the prize

    More than a century has passed since the Nobel Prize in Medicine was awarded for dermatology. ... There are huge unmet needs and the predictions are that the dermatology market will grow significantly over the coming years.

  • Deal Watch January 2018

    Royalty monetisation. 230. Jiangsu Hengrui Medicine/Arcutis. SHR0302, selective JAK inhibitor, for dermatology disorders (currently p2 for RA in China).

  • Pharma deals continue to slide Pharma deals continue to slide

    Roche has licensed a monoclonal antibody in phase II to Dermira, a dermatology company.

  • Deal Watch September 2016 Deal Watch September 2016

    The Vitae acquisition builds Allergan's dermatology pipeline with VTP-43742, a mid stage, orally active RORγt (retinoic acid receptor-related orphan receptor gamma) inhibitor for the potential treatment of psoriasis,

  • Deal Watch August 2016 Deal Watch August 2016

    So the product, which is an orphan drug, ended up in the portfolio of a $10bn company focussed on GI, dermatology and neurology and which was under investigation by the SEC

More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics